ConKay Medical Systems, Inc.
Early-stage medical device company developing minimally invasive technologies to treat valvular regurgitation, with an initial focus on tricuspid valve disease. The company maintains a clinical scientific advisory board of structural heart specialists and has participated in multiple accelerator programs and seed fundraising.
Industries
N/A
Products
Minimally invasive device for treating tricuspid valve regurgitation (in development)
An early-stage cardiovascular device program focused on treating tricuspid valvular regurgitation using minimally invasive/interventional approaches. Program status is development-stage.
Minimally invasive device for treating tricuspid valve regurgitation (in development)
An early-stage cardiovascular device program focused on treating tricuspid valvular regurgitation using minimally invasive/interventional approaches. Program status is development-stage.
Expertise Areas
- Structural heart device development
- Tricuspid valve intervention
- Early-stage medical device R&D
- Clinical advisory and physician engagement
Key Technologies
- Minimally invasive cardiovascular device design
- Transcatheter valve repair methods
- Structural heart intervention techniques